ASBM, in conjunction with the Long Island University College of Pharmacy (LIU-Pharmacy), is now offering a comprehensive continuing education course on biosimilars entitled “Biosimilars: What Pharmacists Need to Know”. The course is accredited by the American Council on Pharmaceutical Education (ACPE), meaning course credit is available to pharmacists nationwide.
The first entry in the series is entitled “Biologic and Biosimilar Medicines: Their Purpose, Development, Structure, and Effects”, and is presented by ASBM Advisory Board Chair, Philip J. Schneider, MS, FASHP.
In the presentation, Dr. Schneider provides a basic overview of biologic medicines and biosimilars, covering topics such as:
- defining biologic medicines and biosimilars
- development and approval
- treatment applications (e.g. rheumatoid arthritis, cancer, etc.)
- Immunogenicity concerns
- safety, storage and handling considerations
- differences between biosimilars and generics
- pharmacovigilance implications
- interchangeability and pharmacy substitution
- recent Federal legislation
The course is offered as a 1 hour CE/homestudy for $10.00, but ASBM is offering the course for FREE when you use the code “BioJune1”.
The user has to visit pharmce.liu.edu and create an account, and then select the course from the catalog. When checking out, the user enters the code.
ASBM and LIU-Pharmacy will be adding additional courses throughout the summer on a wide range of topics including biosimilar substitution practices, non-medical switching, patient and physician perspectives, and biologic pharmacovigilance.
View the first entry in the series here.
